MCA logo
MCA logo



Upadacitinib (Rinvoq): Once-Daily Oral Treatment for Rheumatoid Arthritis (RA)

upadacitinib rinvoq treatment for rheumatoid arthritis (RA)

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

World Hepatitis Day
“One Life, One Liver”: This Year’s Theme For World Hepatitis Day

Hepatitis, a severe liver disease, is devastating the lives of an estimated 354 million individuals. Under the banner “One Life, One Liver,” this year’s World Hepatitis Day emphasises the necessity of boosting viral hepatitis prevention, testing, and treatment efforts. World Hepatitis Day is remember today on 28 July 2023. Despite the presence of efficacious interventions to diagnose, treat and prevent chronic hepatitis B and C, a shocking 82% of hepatitis B patients and 75% of hepatitis C patients remain undiagnosed. With only 5% and 10% receiving treatment respectively, this silent disease is inflicting serious harm on millions of lives.

Read More »
Research team members from Asst Prof Leong Sai Mun’s lab, discussing experimental data for their study on cancer cell altruism. (From left to right: PhD student Poon Kok Siong, Dr Muhammad Sufyan, Dr Tan Yuen Peng, Dr Leong Sai Mun) Breast cancer6
New Study Unveils Altruistic Behaviour of Cancer Cells in Breast Cancer Treatment Resistance

A team from the NUS Centre for Cancer Research (N2CR) and the Department of Pathology at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), has made a significant discovery in the understanding of breast cancer’s resistance to chemotherapy. The study, led by Research Assistant Professor Leong Sai Mun, spanned over a decade and examined a large cohort of breast cancer patients to understand the dynamics of cancer cell survival post-chemotherapy.

Read More »